BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31919754)

  • 1. Liquid Biopsy Applications in the Clinic.
    Chen D; Xu T; Wang S; Chang H; Yu T; Zhu Y; Chen J
    Mol Diagn Ther; 2020 Apr; 24(2):125-132. PubMed ID: 31919754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy: From Basic Research to Clinical Practice.
    Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
    Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future perspectives of liquid biopsies in genomics-driven oncology.
    Heitzer E; Haque IS; Roberts CES; Speicher MR
    Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in liquid biopsy approaches for early detection and monitoring of cancer.
    Babayan A; Pantel K
    Genome Med; 2018 Mar; 10(1):21. PubMed ID: 29558971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature.
    Shoda K; Saito R; Maruyama S; Furuya S; Akaike H; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
    Surg Today; 2021 Jun; 51(6):849-861. PubMed ID: 32979121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liquid biopsy in tumor diagnostics : Applications, perspectives, and limitations of the "cancer liquidome"].
    Lehmann U; Bartels S
    Pathologe; 2019 May; 40(3):250-255. PubMed ID: 31049676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
    Barlebo Ahlborn L; Østrup O
    APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
    Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
    Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dPCR application in liquid biopsies: divide and conquer.
    Moreno-Manuel A; Calabuig-Fariñas S; Obrador-Hevia A; Blasco A; Fernández-Díaz A; Sirera R; Camps C; Jantus-Lewintre E
    Expert Rev Mol Diagn; 2021 Jan; 21(1):3-15. PubMed ID: 33305634
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid Biopsy Based on Circulating Cancer-Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine.
    Jiménez-Zenteno AK; Cerf A
    Adv Biosyst; 2020 Feb; 4(2):e1900164. PubMed ID: 32293131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible.
    Gristina V; La Mantia M; Peri M; Iacono F; Barraco N; Perez A; Viscardi G; Cutaia S; Russo TDB; Anwar Z; Incorvaia L; Fulfaro F; Vieni S; Pantuso G; Graceffa G; Russo A; Galvano A; Bazan V
    Crit Rev Oncol Hematol; 2023 Feb; 182():103899. PubMed ID: 36596401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
    Theil G; Fornara P
    Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention.
    Anagnostou V; Velculescu VE
    Cancer Discov; 2024 Apr; 14(4):615-619. PubMed ID: 38571422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
    Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
    Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications.
    Earl J; Calabuig-Fariñas S; Sarasquete ME; Muinelo Romay L; Lopez-Tarruella S; Bellosillo Paricio B; Rodríguez M; Valencia Leoz K; Dueñas Porto M; Tarazona N; Hernandez Losa J; Toledo RA
    J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.